Literature DB >> 22258914

Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities.

Huda Y Zoghbi1, Mark F Bear.   

Abstract

The discovery of the genetic causes of syndromic autism spectrum disorders and intellectual disabilities has greatly informed our understanding of the molecular pathways critical for normal synaptic function. The top-down approaches using human phenotypes and genetics helped identify causative genes and uncovered the broad spectrum of neuropsychiatric features that can result from various mutations in the same gene. Importantly, the human studies unveiled the exquisite sensitivity of cognitive function to precise levels of many diverse proteins. Bottom-up approaches applying molecular, biochemical, and neurophysiological studies to genetic models of these disorders revealed unsuspected pathogenic mechanisms and identified potential therapeutic targets. Moreover, studies in model organisms showed that symptoms of these devastating disorders can be reversed, which brings hope that affected individuals might benefit from interventions even after symptoms set in. Scientists predict that insights gained from studying these rare syndromic disorders will have an impact on the more common nonsyndromic autism and mild cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258914      PMCID: PMC3282414          DOI: 10.1101/cshperspect.a009886

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  192 in total

1.  MeCP2 mutant protein is expressed in astrocytes as well as in neurons and localizes in the nucleus.

Authors:  L A Kifayathullah; J P Arunachalam; C Bodda; H Y Agbemenyah; F A Laccone; A U Mannan
Journal:  Cytogenet Genome Res       Date:  2010-07-08       Impact factor: 1.636

Review 2.  Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention.

Authors:  Balpreet Bhogal; Thomas A Jongens
Journal:  Dis Model Mech       Date:  2010-08-03       Impact factor: 5.758

Review 3.  Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.

Authors:  Catalina Betancur
Journal:  Brain Res       Date:  2010-12-01       Impact factor: 3.252

4.  The fragile X: a scanning electron microscope study.

Authors:  C J Harrison; E M Jack; T D Allen; R Harris
Journal:  J Med Genet       Date:  1983-08       Impact factor: 6.318

5.  The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Authors:  Qiang Chang; Gargi Khare; Vardhan Dani; Sacha Nelson; Rudolf Jaenisch
Journal:  Neuron       Date:  2006-02-02       Impact factor: 17.173

6.  Rett syndrome: long-term clinical follow-up experiences over four decades.

Authors:  Bengt Hagberg
Journal:  J Child Neurol       Date:  2005-09       Impact factor: 1.987

7.  Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.

Authors:  Lynsey Meikle; Kristen Pollizzi; Anna Egnor; Ioannis Kramvis; Heidi Lane; Mustafa Sahin; David J Kwiatkowski
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

8.  Disruption of neurexin 1 associated with autism spectrum disorder.

Authors:  Hyung-Goo Kim; Shotaro Kishikawa; Anne W Higgins; Ihn-Sik Seong; Diana J Donovan; Yiping Shen; Eric Lally; Lauren A Weiss; Juliane Najm; Kerstin Kutsche; Maria Descartes; Lynn Holt; Stephen Braddock; Robin Troxell; Lee Kaplan; Fred Volkmar; Ami Klin; Katherine Tsatsanis; David J Harris; Ilse Noens; David L Pauls; Mark J Daly; Marcy E MacDonald; Cynthia C Morton; Bradley J Quade; James F Gusella
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

9.  Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice.

Authors:  Daniela Tropea; Emanuela Giacometti; Nathan R Wilson; Caroline Beard; Cortina McCurry; Dong Dong Fu; Ruth Flannery; Rudolf Jaenisch; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

10.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.

Authors:  João Peça; Cátia Feliciano; Jonathan T Ting; Wenting Wang; Michael F Wells; Talaignair N Venkatraman; Christopher D Lascola; Zhanyan Fu; Guoping Feng
Journal:  Nature       Date:  2011-03-20       Impact factor: 49.962

View more
  304 in total

1.  More Than mTOR? Novel Roles for MEK-ERK1/2 and FLNA in Tuberous Sclerosis Complex.

Authors:  Chris G Dulla
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

Review 2.  Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders.

Authors:  Mustafa Sahin; Mriganka Sur
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

3.  Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.

Authors:  Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer
Journal:  Neuron       Date:  2014-08-21       Impact factor: 17.173

Review 4.  EphBs and ephrin-Bs: Trans-synaptic organizers of synapse development and function.

Authors:  Nathan T Henderson; Matthew B Dalva
Journal:  Mol Cell Neurosci       Date:  2018-07-19       Impact factor: 4.314

Review 5.  LTD-like molecular pathways in developmental synaptic pruning.

Authors:  Claire Piochon; Masanobu Kano; Christian Hansel
Journal:  Nat Neurosci       Date:  2016-09-27       Impact factor: 24.884

6.  Alleviation of N-Methyl-D-Aspartate Receptor-Dependent Long-Term Depression via Regulation of the Glycogen Synthase Kinase-3β Pathway in the Amygdala of a Valproic Acid-Induced Animal Model of Autism.

Authors:  Han-Fang Wu; Po See Chen; Yi-Ju Chen; Chi-Wei Lee; I-Tuan Chen; Hui-Ching Lin
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

Review 7.  Activity-dependent neuronal signalling and autism spectrum disorder.

Authors:  Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

8.  Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range.

Authors:  Regina Waltes; Johannes Gfesser; Denise Haslinger; Katja Schneider-Momm; Monica Biscaldi; Anette Voran; Christine M Freitag; Andreas G Chiocchetti
Journal:  J Neural Transm (Vienna)       Date:  2014-05-13       Impact factor: 3.575

9.  Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome.

Authors:  Wei-Hsiang Huang; Casey J Guenthner; Jin Xu; Tiffany Nguyen; Lindsay A Schwarz; Alex W Wilkinson; Or Gozani; Howard Y Chang; Mehrdad Shamloo; Liqun Luo
Journal:  Neuron       Date:  2016-09-29       Impact factor: 17.173

10.  Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities.

Authors:  J L Mohn; J Alexander; A Pirone; C D Palka; S-Y Lee; L Mebane; P G Haydon; M H Jacob
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.